Summary
- Current Price
- As of today, VNDA price is $5.92, down -2.95% in the most recent trading session on
- Current Price All-Time High
- VNDA price is currently -82.30% below its historical high of $33.44 set on
- Market Cap
- VNDA current market cap is $350M, up +33.61% over the past 365 days
- PE Ratio
- VNDA PE ratio is unknown
- Revenue
- VNDA current annual revenue is $216.11M, up +8.72% year-over-year
- Next Earnings
- The next earnings release for VNDA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Vanda Pharmaceuticals Inc. |
| Ticker | NASDAQ: VNDA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vandapharma.com |
| Employees | 368 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.92 | ||
| Price, 1D Change | -2.95% | |
| $350M | ||
| - | ||
| - | ||
| 0.63 | ||
| $216M | ||
| Revenue, 1Y Change | +8.72% | |
| -$3.74 | ||
| EPS, 1Y Change | -1,051.17% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.74 | ||
| EPS Estimate | N/A | -$1.12 |
| EPS Est. Change | N/A | +69.98% |
| $216.11M | ||
| Revenue Estimate | N/A | $260.75M |
| Revenue Est. Change | N/A | +20.66% |
| $5.92 | ||
| Price Target | - | $12.50 |
| Price Tgt. Change | - | +111.15% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.33 | - | |
| -$2.67 | -$3.74 | -39.99% | |
| -$1.12 | N/A | +69.98% | |
| -$0.51 | N/A | +86.28% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $199.45M | $198.77M | -0.34% | |
| $218.17M | $216.11M | -0.95% | |
| $260.75M | N/A | +20.66% | |
| $367.30M | N/A | +69.96% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +31.85% | ||
| -16.15% | ||
| +33.61% | ||
| -12.73% | ||
| +8.72% | ||
| -15.05% | ||
| -1,051.17% | ||
| -3,498.09% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $5.92 | ||
| $5.33 | ||
| SMA 200 vs Price | -9.90% | |
| $7.26 | ||
| SMA 50 vs Price | +22.55% | |
| 0.63 | ||
| $0.45 | ||
| 35.43 | ||
| 96.33% | ||
| 64.35% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $216.11M | ||
| -$3.74 | ||
| $196.05M | ||
| 90.72% | ||
| -$151.17M | ||
| -69.95% | ||
| -$220.47M | ||
| -102.02% | ||
| -$139.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 2.39 | ||
| 2.38 | ||
| - | ||
| 3 | ||
| 0.09 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.62 | ||
| 1.07 | ||
| -0.71 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $327.19M | ||
| $263.85M | ||
| $488.95M | ||
| $347.26M | ||
| $161.76M | ||
| $145.16M | ||
| $12.62M | ||
| $5.56M | ||
| $7.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $436.58M | ||
| $347.22M | ||
| $20.05M | ||
| $0.00 | ||
| $11.92M | ||
| $0.00 | ||
| $81.83M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$109.44M | ||
| $94.86M | ||
| -$2.91M | ||
| $998.00K | ||
| -$110.44M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Jefferies | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | ||
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with VNDA
FAQ
What is the ticker symbol for Vanda Pharmaceuticals Inc.?
The ticker symbol for Vanda Pharmaceuticals Inc. is NASDAQ:VNDA
Does Vanda Pharmaceuticals Inc. pay dividends?
No, Vanda Pharmaceuticals Inc. does not pay dividends
What sector is Vanda Pharmaceuticals Inc. in?
Vanda Pharmaceuticals Inc. is in the Healthcare sector
What industry is Vanda Pharmaceuticals Inc. in?
Vanda Pharmaceuticals Inc. is in the Biotechnology industry
What country is Vanda Pharmaceuticals Inc. based in?
Vanda Pharmaceuticals Inc. is headquartered in United States
When did Vanda Pharmaceuticals Inc. go public?
Vanda Pharmaceuticals Inc. initial public offering (IPO) was on April 12, 2006
Is Vanda Pharmaceuticals Inc. in the S&P 500?
No, Vanda Pharmaceuticals Inc. is not included in the S&P 500 index
Is Vanda Pharmaceuticals Inc. in the NASDAQ 100?
No, Vanda Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is Vanda Pharmaceuticals Inc. in the Dow Jones?
No, Vanda Pharmaceuticals Inc. is not included in the Dow Jones index
When was Vanda Pharmaceuticals Inc. last earnings report?
Vanda Pharmaceuticals Inc.'s most recent earnings report was on February 11, 2026
When does Vanda Pharmaceuticals Inc. report earnings?
The next expected earnings date for Vanda Pharmaceuticals Inc. is May 6, 2026
Data Sources & References
- VNDA Official Website www.vandapharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1347178/000162828026007460/0001628280-26-007460-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1347178/000162828026007460/0001628280-26-007460-index.htm
- VNDA Profile on Yahoo Finance finance.yahoo.com/quote/VNDA
- VNDA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vnda